The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Intravascular hemolysis and the pathophysiology of sickle cell disease
Open accessAbstract
flow, normoxia to hypoxia, isotonic to hypertonic environment, and acidotic to alkalotic milieu.Multiple components contribute to sickle hemoglobinopathy pathophysiology, including primary components arising from HbS polymerization and secondary components that are downstream effects of the HbS polymer. Understanding how these components' complexity is compounded by genetic and environmental modulation provides insight into the well-known clinical heterogeneity of sickle cell disease (SCD).A cardinal feature of SCD pathogenesis involves inflammation, accompanied by heterocellular leukocyte-platelet-erythrocyte-endothelial adhesive events that trigger vaso-occlusive episodes, acute organ ischemia, and reperfusion injury.Twenty-five years ago, epidemiological studies identified leukocytosis, lower HbF levels, and higher total hemoglobin levels as risk factors associated with increasing incidence of acute painful episodes and acute chest syndrome (ACS) (5).The independent association of high total hemoglobin levels with more pain, ACS events, and osteonecrosis was never mechanistically explained; however, it was implied to be a result of increased blood viscosity (Table 1).Recent epidemiological studies found that lower hemoglobin levels and higher intensity of steady-state hemolytic anemia consistently associate with vasculopathic complications of disease, such as stroke, leg ulcers, PH, priapism, and renal failure.This suggests that certain subphenotypes of SCD relate more to hemolytic anemia severity rather than sickle vaso-occlusion.The reader is referred to recent reviews describing the exceptional strides made in understanding the roles of red cell rigidity (6), inflammation, and cell adhesion in sickle vaso-occlusion (7-9).Here, we review the complementary role of intravascular hemolysis and anemia.Hemolysis is a fundamental feature of sickle cell anemia that contributes to its pathophysiology and phenotypic variability.Decompartmentalized hemoglobin, arginase 1, asymmetric dimethylarginine, and adenine nucleotides are all products of hemolysis that promote vasomotor dysfunction, proliferative vasculopathy, and a multitude of clinical complications of pulmonary and systemic vasculopathy, including pulmonary hypertension, leg ulcers, priapism, chronic kidney disease, and large-artery ischemic stroke.Nitric oxide (NO) is inactivated by cell-free hemoglobin in a dioxygenation reaction that also oxidizes hemoglobin to methemoglobin, a non-oxygen-binding form of hemoglobin that readily loses heme.Circulating hemoglobin and heme represent erythrocytic danger-associated molecular pattern (eDAMP) molecules, which activate the innate immune system and endothelium to an inflammatory, proadhesive state that promotes sickle vaso-occlusion and acute lung injury in murine models of sickle cell disease.Intravascular hemolysis can impair NO bioavailability and cause oxidative stress, altering redox balance and amplifying physiological processes that govern blood flow, hemostasis, inflammation, and angiogenesis.These pathological responses promote regional vasoconstriction and subsequent blood vessel remodeling.Thus, intravascular hemolysis represents an intrinsic mechanism for human vascular disease that manifests clinical complications in sickle cell disease and other chronic hereditary or acquired hemolytic anemias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [58]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Once released, IL-1β binds to IL-1 receptor (IL-1R) on leukocytes and vascular cells, promoting a cascade of downstream events that lead to activation of neutrophils and platelets and upregulation of E-selectin, P-selectin, VCAM-1, ICAM-1, and chemokines such as IL-8 in endothelial cells, all of which promote vaso-occlusion (14, 17) (Figure 1).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vaso-occlusion contributes to ischemia-reperfusion injury, which, along with release of eDAMPs, promotes the progression of sterile inflammation (Figure 1d) in SCD (14, 17, 18).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in adults with SCD lend further support to the role of hemolysis by showing a link between the hyperhemolysis phenotype of SCD and stroke risk (17).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Unequal protection by HbF across the gamut of sickle cell disease complications might be partially explained by differences in the pathophysiologic roots of these complications.57,58”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“Acute painful episodes and acute chest syndrome are a result of sickle vasoocclusion; HbF has the most noticeable beneficial effect on these subphenotypes.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Survival in Patients with Primary Pulmonary Hypertension
D’Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. Μ., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,488
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 1×
“Mortality Increases risk (19, 39, 42, 47, 49, 64, 188) Protective (189) Protective (190)”
Self-citationCerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
Rother, R. P., Bell, L. B., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,565
Self-citationPain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Self-citationCastro, O. L., Brambilla, D. J., Thorington, B. D., Reindorf, C. A., Scott, R., GILLETTE, P. N., Vera, J., & Levy, P. S. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 805
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 769
Belcher, J. D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A. I., Smith, A., Nath, K. A., Hebbel, R. P., & Vercellotti, G. M. (2014) · Blood · doi:10.1182/blood-2013-04-495887 · Cited by 695
Kato, G. J., McGowan, V., Machado, R. F., Little, J. A., Taylor, J., Morris, C. R., Nichols, J. S., Wang, X., Poljakovic, M., Morris, S. M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2373 · Cited by 661
Self-citationOxidation of nitrogen-oxides by bound dioxygen in hemoproteins
Doyle, M. P., & Hoekstra, J. W. (1981) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(00)80291-3 · Cited by 643
Castro, O. L., Brambilla, D. J., Thorington, B. D., et al. (1994) · Blood · doi:10.1182/blood.v84.2.643.bloodjournal842643 · Cited by 615
ATMOSPHERIC OZONE AND FEMORAL FRACTURES
Burton, J. L., Ensell, F. J., Leach, J. F., & Hall, K. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92450-2 · Cited by 587
Donadee, C., Raat, N. J. H., Kanias, T., Tejero, J., Lee, J. S., Kelley, E. E., Zhao, X., Liu, C., Reynolds, H., Azarov, I., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.008698 · Cited by 584
Self-citationFetal hemoglobin in sickle cell anemia
Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H. K., & Steinberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-03-325258 · Cited by 553
Self-citationGill, F., Sleeper, L., Weiner, S. R., Ak, B., Bellevue, R., Grover, R., Pegelow, C. H., & Vichinsky, E. P. (1995) · Blood · doi:10.1182/blood.v86.2.776.bloodjournal862776 · Cited by 513
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S. L., Savale, L., Adnot, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005565 · Cited by 511
Prediction of Adverse Outcomes in Children with Sickle Cell Disease
Miller, S. T., Sleeper, L. A., Pegelow, C. H., Enos, L. E., Wang, W. C., Weiner, S. J., Wethers, D. L., Smith, J., & Kinney, T. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420203 · Cited by 508
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
Sickle Cell Disease as a Cause of Osteonecrosis of the Femoral Head
Milner, P. F. A., Kraus, A. P., Sebes, J. I., Sleeper, L. A., Dukes, K. A., Embury, S. H., Bellevue, R., Koshy, M., Moohr, J. W., & Smith, J. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252104 · Cited by 384
Chronic Renal Failure in Sickle Cell Disease: Risk Factors, Clinical Course, and Mortality
Powars, D. R., Elliott-Mills, D. D., Chan, L. S., Niland, J. C., Hiti, A. L., Opas, L. M., & Johnson, C. S. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-614 · Cited by 357
Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease
Chen, G., Zhang, D., Fuchs, T. A., Manwani, D., Wagner, D. D., & Frenette, P. S. (2014) · Blood · doi:10.1182/blood-2013-10-529982 · Cited by 354
Hemolysis-induced lethality involves inflammasome activation by heme
Dutra, F. F., Alves, L. S., Rodrigues, D., Fernandez, P. L., de Oliveira, R. B., Golenbock, D. T., Zamboni, D. S., & Bozza, M. T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405023111 · Cited by 353
Minneci, P. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25040 · Cited by 336
Genetic modifiers of sickle cell disease
Steinberg, M. H., & Sebastiani, P. (2012) · American Journal of Hematology · doi:10.1002/ajh.23232 · Cited by 315
Self-citationBarabino, G. A., Platt, M. O., & Kaul, D. K. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105339 · Cited by 311
Silent cerebral infarcts in sickle cell anemia: a risk factor analysis
Kinney, T. R., Sleeper, L. A., Wang, W. C., Zimmerman, R. A., Pegelow, C. H., Ohene-Frempong, K., Wethers, D. L., Bello, J. A., Vichinsky, E. P., Moser, F. G., et al. (1999) · PEDIATRICS · doi:10.1542/peds.103.3.640 · Cited by 309
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study
Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06110.x · Cited by 298
Yeo, T. W., Lampah, D. A., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y., Darcy, C. J., Granger, D. L., Weinberg, J. B., Lopansri, B. K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070819 · Cited by 297
Extracellular hemin crisis triggers acute chest syndrome in sickle mice
Ghosh, S., Adisa, O. A., Chappa, P., Tan, F., Jackson, K. A., Archer, D. R., & Ofori-Acquah, S. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64578 · Cited by 282
Baek, J. H., D’Agnillo, F., Vallelian, F., Pereira, C. P., Williams, M. C., Jia, Y., Schaer, D. J., & Buehler, P. W. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59770 · Cited by 280
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Fonsêca, G. H. H., Souza, R., Salemi, V. M. C., Jardim, C., & Gualandro, S. F. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00134410 · Cited by 274
Anthi, A., Machado, R. F., Jison, M. L., Taveira‐DaSilva, A. M., Rubin, L. J., Hunter, L. A., Hunter, C. J., Coles, W. A., Nichols, J., Avila, N. A., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1498oc · Cited by 270
Self-citationVinchi, F., Costa da Silva, M., Ingoglia, G., Petrillo, S., Brinkman, N., Zuercher, A., Cerwenka, A., Tolosano, E., & Muckenthaler, M. U. (2016) · Blood · doi:10.1182/blood-2015-08-663245 · Cited by 269
Fetal hemoglobin in sickle cell anemia: a glass half full?
Steinberg, M. H., Chui, D. H. K., Dover, G. J., Sebastiani, P., & Alsultan, A. (2014) · Blood · doi:10.1182/blood-2013-09-528067 · Cited by 267
Self-citationCamus, S. M., Moraes, J. A., Bonnin, P., Abbyad, P., Jeune, S. L., Lionnet, F., Loufrani, L., Grimaud, L., Lambry, J., Charue, D., et al. (2015) · Blood · doi:10.1182/blood-2014-07-589283 · Cited by 266
Hsu, L. L., Champion, H. C., Campbell-Lee, S. A., Bivalacqua, T. J., Manci, E. A., Diwan, B. A., Schimel, D. M., Cochard, A. E., Wang, X., Schechter, A. N., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039438 · Cited by 263
Self-citationHeme Degradation and Vascular Injury
Belcher, J. D., Beckman, J. D., Balla, G., Balla, J., & Vercellotti, G. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2822 · Cited by 257
Machado, R. F., Barst, R. J., Yovetich, N. A., Hassell, K. L., Kato, G. J., Gordeuk, V. R., Gibbs, J. S. R., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Blood · doi:10.1182/blood-2010-09-306167 · Cited by 253
Self-citationCastro, L. M. D., Jonassaint, J., Graham, F. L., Ashley‐Koch, A. E., & Telen, M. J. (2007) · American Journal of Hematology · doi:10.1002/ajh.21058 · Cited by 243
Leg ulcers in patients with sickle cell disease [see comments]
Koshy, M., Entsuah, R., Koranda, A., Kraus, A., Johnson, R., Bellvue, R., Flournoy-Gill, Z., & Levy, P. S. (1989) · Blood · doi:10.1182/blood.v74.4.1403.1403 · Cited by 239
Hemoglobins S and C Interfere with Actin Remodeling in Plasmodium falciparum –Infected Erythrocytes
Cyrklaff, M., Sanchez, C. P., Kilian, N., Bisseyé, C., Simporè, J., Frischknecht, F., & Lanzer, M. (2011) · Science · doi:10.1126/science.1213775 · Cited by 239
Nouraie, M. S., Lee, J. S., Zhang, Y., Kanias, T., Zhao, X., Xiong, Z., Oriss, T. B., Zeng, Q., Kato, G. J., Gibbs, J. S. R., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.068965 · Cited by 237
Self-citationNitric oxide donor properties of hydroxyurea in patients with sickle cell disease
Gladwin, M. T., Shelhamer, J. H., Ognibene, F. P., Pease‐Fye, M. E., Nichols, J. S., Link, B., Patel, D. B., Jankowski, M. A., Pannell, L. K., Schechter, A. N., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03274.x · Cited by 234
Self-citationVinchi, F., Franceschi, L. D., Ghigo, A., Townes, T. M., Cimino, J. J., Silengo, L., Hirsch, E., Altruda, F., & Tolosano, E. (2013) · Circulation · doi:10.1161/circulationaha.112.130179 · Cited by 233
Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension
Mehari, A., Gladwin, M. T., Tian, X., Machado, R. F., & Kato, G. J. (2012) · JAMA · doi:10.1001/jama.2012.358 · Cited by 229
Self-citationPriapism and Impotence in Homozygous Sickle Cell Disease
Emond, A. M. (1980) · Archives of Internal Medicine · doi:10.1001/archinte.1980.00330220022011 · Cited by 229
Ataga, K. I., Reid, M. E., Ballas, S. K., Yasin, Z., Bigelow, C. L., James, L. S., Smith, W. R., Galactéros, F., Kutlar, A., Hull, J. H., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08520.x · Cited by 227
Jison, M. L., Munson, P. J., Barb, J. J., Suffredini, A. F., Talwar, S., Logun, C., Raghavachari, N., Beigel, J. H., Shelhamer, J. H., Danner, R. L., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2760 · Cited by 220
Self-citationHemolysis-associated priapism in sickle cell disease
Nolan, V. G., Wyszynski, D. F., Farrer, L. A., & Steinberg, M. H. (2005) · Blood · doi:10.1182/blood-2005-04-1594 · Cited by 218
Self-citationLow nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria
Gramaglia, I., Sobolewski, P., Meays, D., Contreras, R., Nolan, J. P., Frangos, J. A., Intaglietta, M., & van der Heyde, H. C. (2006) · Nature Medicine · doi:10.1038/nm1499 · Cited by 215
Pulmonary hypertension and nitric oxide depletion in sickle cell disease
Bunn, H. F., Nathan, D. G., Dover, G. J., Hebbel, R. P., Platt, O. S., Rosse, W. F., & Ware, R. E. (2010) · Blood · doi:10.1182/blood-2010-02-268193 · Cited by 204
N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
Machado, R. F., Anthi, A., Steinberg, M. H., Bonds, D., Sachdev, V., Kato, G. J., Taveira-DaSilva, A. M., Ballas, S. K., Blackwelder, W., Xu, X., et al. (2006) · JAMA · doi:10.1001/jama.296.3.310 · Cited by 197
Self-citationHemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease
Gladwin, M. T., Kanias, T., & Kim-Shapiro, D. B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62972 · Cited by 196
Self-citationNaik, R. P. P., Streiff, M. B., Haywood, C., Nelson, J. A., & Lanzkron, S. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.016 · Cited by 190
The Redox Activity of Hemoglobins: From Physiologic Functions to Pathologic Mechanisms
Reeder, B. J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2974 · Cited by 189
Minniti, C. P., Sable, C., Campbell, A., RANA, S. R., Ensing, G. J., Dham, N., Onyekwere, O. C., Nouraie, M. S., Kato, G. J., Gladwin, M. T., et al. (2009) · Haematologica · doi:10.3324/haematol.13812 · Cited by 186
Self-citationTaylor, J. G., Nolan, V. G., Mendelsohn, L. G., Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002095 · Cited by 185
Self-citationSilent infarcts in young children with sickle cell disease
Kwiatkowski, J. L., Zimmerman, R. A., Pollock, A. N., Seto, W., Smith‐Whitley, K., Justine Shults, A., Blackwood‐Chirchir, A., & Ohene‐Frempong, K. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07753.x · Cited by 184
Hebbel, R. P. (2010) · American Journal of Hematology · doi:10.1002/ajh.21952 · Cited by 171
Glomerular Hyperfiltration in Adult Sickle Cell Anemia
Haymann, J., Stankovic, K., Lévy, P., Avellino, V., Tharaux, P., Letavernier, E., Grateau, G., Baud, L., Girot, R., & Lionnet, F. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08511109 · Cited by 166
SICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES
Wood, K. C., & Granger, D. N. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04639.x · Cited by 164
Red cell DAMPs and inflammation
Mendonça, R., Silveira, A. A. A., & Conran, N. (2016) · Inflammation Research · doi:10.1007/s00011-016-0955-9 · Cited by 163
Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M., & Delacourt, C. (2008) · Blood · doi:10.1182/blood-2008-03-143891 · Cited by 162
The painful crisis of homozygous sickle cell disease. A study of the risk factors
Baum, K. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.7.1231 · Cited by 161
Pulmonary hypertension in sickle cell disease
Ataga, K. I., Sood, N., Gent, G. D., Kelly, E. A., Henderson, A. G., Jones, S., Strayhorn, D., Lail, A. E., Lieff, S., & Orringer, E. P. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.034 · Cited by 151
Cárdenes, N., Corey, C. G., Geary, L., Jain, S., Zharikov, S. I., Barge, S., Novelli, E. M., & Shiva, S. (2014) · Blood · doi:10.1182/blood-2013-09-529420 · Cited by 150
Heme: Modulator of Plasma Systems in Hemolytic Diseases
Roumenina, L. T., Rayes, J., Lacroix‐Desmazes, S., & Dimitrov, J. D. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.004 · Cited by 149
Red alert: labile heme is an alarmin
Soares, M. P., & Bozza, M. T. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.11.006 · Cited by 148
Sachdev, V., Kato, G. J., Gibbs, J. S. R., Barst, R. J., Machado, R. F., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.032920 · Cited by 147
Self-citationEmbury, S., Clark, M. R., Monroy, G., & Mohandas, N. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111181 · Cited by 145
Sabaa, N., Franceschi, L. D., Bonnin, P., Castier, Y., Malpeli, G., Debbabi, H., Galaup, A., Maïer-Redelsperger, M., Vandermeersch, S., Scarpa, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33308 · Cited by 145
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease
Niss, O., Quinn, C. T., Lane, A., Daily, J., Khoury, P. R., Bakeer, N., Kimball, T. R., Towbin, J. A., Malik, P., & Taylor, M. D. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.05.013 · Cited by 142
Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial
Ware, R. E., Rees, R. C., Sarnaik, S. A., Iyer, R. V., Alvarez, O. A., Casella, J. F., Shulkin, B. L., Shalaby-Rana, E. I., Strife, C. F., Miller, J. H., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.06.060 · Cited by 138
Reactive Species in Sickle Cell Disease
ASLAN, M., THORNLEY‐BROWN, D., & FREEMAN, B. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06201.x · Cited by 136
Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease
Mehari, A., Alam, S., Tian, X., Cuttica, M. J., Barnett, C. F., Miles, G., Xu, D., Seamon, C., Adams-Graves, P., Castro, O. L., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1222oc · Cited by 135
Self-citationYeo, T. W., Lampah, D. A., Tjitra, E., Gitawati, R., Kenangalem, E., Piera, K., Granger, D. L., Lopansri, B. K., Weinberg, J. B., Price, R. N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/644641 · Cited by 132
Gladwin, M. T., Barst, R. J., Gibbs, J. S. R., Hildesheim, M., Sachdev, V., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099489 · Cited by 132
Self-citationThe Painful Crisis of Homozygous Sickle Cell Disease
Baum, K. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370070045007 · Cited by 124
The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization.
Hebbel, R. P. (1990) · PubMed · Cited by 123
Inhaled Nitric Oxide Enables Artificial Blood Transfusion Without Hypertension
Yu, B., Raher, M. J., Volpato, G. P., Bloch, K. D., Ichinose, F., & Zapol, W. M. (2008) · Circulation · doi:10.1161/circulationaha.107.729137 · Cited by 122
Derchi, G., Galanello, R., Bina, P., Cappellini, M. D., Piga, A. G., Lai, M.-E., Quarta, A., Casu, G., Perrotta, S., Pinto, V. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002124 · Cited by 122
Association between hemolysis and albuminuria in adults with sickle cell anemia
Day, T. G., Drašar, E., Fulford, T. J., Sharpe, C. C., & Thein, S. L. (2011) · Haematologica · doi:10.3324/haematol.2011.050336 · Cited by 122
Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse
Kaul, D. K., Liu, X.-D., Fabry, M. E., & Nagel, R. L. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h1799 · Cited by 122
Repka, T. L., & Hebbel, R. (1991) · Blood · doi:10.1182/blood.v78.10.2753.2753 · Cited by 121
Saraf, S. L., Zhang, X., Kanias, T., Lash, J. P., Molokie, R. E., Oza, B., Lai, C., Rowe, J. H., Gowhari, M., Hassan, J., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12690 · Cited by 120
Self-citationThe effect of fetal hemoglobin on the survival characteristics of sickle cells
Franco, R. S., Yasin, Z., Palascak, M. B., Ciraolo, P., Joiner, C. H., & Rucknagel, D. L. (2006) · Blood · doi:10.1182/blood-2005-09-008318 · Cited by 119
Ballas, S. K., & Marcolina, M. J. (2005) · Transfusion · doi:10.1111/j.1537-2995.2006.00679.x · Cited by 114
Erythroid DAMPs drive inflammation in SCD
Gladwin, M. T., & Ofori-Acquah, S. F. (2014) · Blood · doi:10.1182/blood-2014-03-563874 · Cited by 113
Self-citationFabry, M. E., & Nagel, R. L. (1982) · PubMed · Cited by 111
Baldwin, C. T., Nolan, V. G., Wyszynski, D. F., Ma, Q., Paola Sebastiani, B., Embury, S. H., Bisbee, A. B., Farrell, J. J., Farrer, L. A., & Steinberg, M. H. (2005) · Blood · doi:10.1182/blood-2005-02-0548 · Cited by 110
Self-citationEffect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice
Kaul, D. K., Liu, X.-D., Chang, H.-Y., Nagel, R. L., & Fabry, M. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21633 · Cited by 109
Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis
Schaer, C. A., Deuel, J., Schildknecht, D., Mahmoudi, L., García‐Rubio, I., Owczarek, C. M., Schauer, S., Kissner, R., Banerjee, U., Palmer, A. F., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2058oc · Cited by 108
Darbari, D. S., Onyekwere, O. C., Nouraie, M. S., Minniti, C. P., Luchtman‐Jones, L., RANA, S. R., Sable, C., Ensing, G. J., Dham, N., Campbell, A., et al. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.07.018 · Cited by 105
Self-citationHsu, L. L.-Y., Miller, S. T., Wright, E. C., Kutlar, A., McKie, V. C., Wang, W. C., Pegelow, C. H., Driscoll, C., Hurlet, A., Woods, G. M., et al. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200308000-00007 · Cited by 103
Prevelance and clinical correlates of glomerulopathy in children with sickle cell disease
Wigfall, D. R., Ware, R. E., Burchinal, M., Kinney, T. R., & Foreman, J. W. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)48828-1 · Cited by 101
Iron, Inflammation, and Early Death in Adults With Sickle Cell Disease
van Beers, E. J., Yang, Y., Raghavachari, N., Tian, X., Allen, D. T., Nichols, J. S., Mendelsohn, L. G., Nekhai, S. A., Gordeuk, V. R., Taylor, J. G., et al. (2014) · Circulation Research · doi:10.1161/circresaha.116.304577 · Cited by 100
Self-citationJohnson, M. C., Kirkham, F. J., Redline, S. S., ROSEN, C. L., Yan, Y., Roberts, I. A. G., Gruenwald, J., Marek, J., & DeBaun, M. R. (2010) · Blood · doi:10.1182/blood-2009-06-227447 · Cited by 99
Pulmonary Hypertension in Children and Adolescents with Sickle Cell Disease
Onyekwere, O. C., Campbell, A., Teshome, M., Onyeagoro, S., Sylvan, C., Akintilo, A., Hutchinson, S. K., Ensing, G. J., Gaskin, P. R. A., Kato, G. J., et al. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9018-x · Cited by 99
Self-citationThe metabolism of hemoglobin and bile pigment in hemolytic disease
Crosby, W. H. (1955) · The American Journal of Medicine · doi:10.1016/0002-9343(55)90208-4 · Cited by 98
Zorca, S. M., Freeman, L. A., Hildesheim, M. E., Allen, D. T., Remaley, A. T., Taylor, J. G., & Kato, G. J. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08109.x · Cited by 96
Self-citationAlpha-thalassemia is related to prolonged survival in sickle cell anemia
Mears, J., Lachman, H., Labie, D., & Nagel, R. L. (1983) · Blood · doi:10.1182/blood.v62.2.286.bloodjournal622286 · Cited by 93
Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity.
Noguchi, C. T., Torchia, D. A., & Schechter, A. N. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111055 · Cited by 92
Quinn, C. T., Lee, N. J., Shull, E. P., Ahmad, N., Rogers, Z. R., & Buchanan, G. R. (2007) · Blood · doi:10.1182/blood-2007-07-100719 · Cited by 90
Guasch, A., Zayas, C. F., Eckman, J. R., Muralidharan, K., Zhang, W., & Elsas, L. J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1051014 · Cited by 90
O-Thalassemia Reduces the Hemolytic Rate in Homozygous Sickle-Cell Disease
Ceulaer, K. D., Higgs, D. R., Weatherall, D. J., Hayes, R., Serjeant, B. E., & Serjeant, G. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307213090320 · Cited by 89
MRI abnormalities of the brain in one‐year‐old children with sickle cell anemia
Wang, W. C., Pavlakis, S. G., Helton, K. J., McKinstry, R. C., Casella, J. F., Adams, R. J., & Rees, R. C. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21612 · Cited by 86
Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease
Becton, L. J., Kalpatthi, R. V., Rackoff, E., Disco, D., Orak, J. K., Jackson, S. M., & Shatat, I. F. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1536-8 · Cited by 85
High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension
Sundaram, N., Tailor, A., Mendelsohn, L. G., Wansapura, J. P., Wang, X., Higashimoto, T., Pauciulo, M. W., Gottliebson, W. M., Kalra, V. K., Nichols, W. C., et al. (2010) · Blood · doi:10.1182/blood-2009-09-244830 · Cited by 85
Self-citationGordeuk, V. R., Minniti, C. P., Nouraie, M. S., Campbell, A., RANA, S. R., Luchtman‐Jones, L., Sable, C., Dham, N., Ensing, G. J., Prchal, J. T., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.030767 · Cited by 85
Self-citationExcess of heme induces tissue factor-dependent activation of coagulation in mice
Sparkenbaugh, E., Chantrathammachart, P., Wang, S., Jonas, W., Kirchhofer, D., Gailani, D., Gruber, A., Kasthuri, R. S., Key, N. S., Mackman, N., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.114728 · Cited by 85
Vasavda, N., Menzel, S., Kondaveeti, S., Maytham, E. G., Awogbade, M., Bannister, S., Cunningham, J., Eichholz, A., Daniel, Y., Okpala, I. E., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06643.x · Cited by 83
Serghides, L., Kim, H., Lu, Z., Kain, D. C., Miller, C., Francis, R. C. E., Liles, W. C., Zapol, W. M., & Kain, K. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027714 · Cited by 83
Bean, C. J., Boulet, S. L., Ellingsen, D., Pyle, M., Barron‐Casella, E. A., Casella, J. F., Payne, A. B., Driggers, J., Trau, H. A., Yang, G., et al. (2012) · Blood · doi:10.1182/blood-2011-06-361642 · Cited by 83
Almeida, C. B., de Souza, L. E. B., Leonardo, F. C., Costa, F. T. M., WERNECK, C. C., Covas, D. T., Costa, F. F., & Conran, N. (2015) · Blood · doi:10.1182/blood-2014-12-616250 · Cited by 81
Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease
Wigfall, D. R., Ware, R. E., Burchinal, M., Kinney, T. R., & Foreman, J. W. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.105998 · Cited by 80
Yuditskaya, S., Tumblin, A. R., Hoehn, G., Wang, G., Drake, S. K., Xu, X., Ying, S., Amy, H., Remaley, A. T., Shen, R., et al. (2008) · Blood · doi:10.1182/blood-2008-03-142604 · Cited by 79
Self-citationSickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology
Bakeer, N., James, J., Roy, S., Wansapura, J., Shanmukhappa, S. K., Lorenz, J. N., Osinska, H., Backer, K., Huby, A.-C., Shrestha, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600311113 · Cited by 79
Fetal haemoglobin and early manifestations of homozygous sickle cell disease.
Bailey, K. A., Morris, J., Thomas, P., & Serjeant, G. R. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.4.517 · Cited by 78
Hhawker, H., Neilson, H., Hayes, R., & Serjeant, G. R. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb01887.x · Cited by 77
Autologous Transfusion of Stored Red Blood Cells Increases Pulmonary Artery Pressure
Berra, L. M., Pinciroli, R., Stowell, C. P., Wang, L., Yu, B., Fernandez, B. O., Feelisch, M., Mietto, C., Hod, E. A., Chipman, D., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0850oc · Cited by 74
Detterich, J. A., Kato, R. M., Rábai, M., Meiselman, H. J., Coates, T. D., & Wood, J. C. (2015) · Blood · doi:10.1182/blood-2014-12-614370 · Cited by 70
Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function
Risbano, M. G., Kanias, T., Triulzi, D. J., Donadee, C., Barge, S., Badlam, J. B., Jain, S., Belanger, A., Kim‐Shapiro, D. B., & Gladwin, M. T. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0145oc · Cited by 70
Self-citationHu, W., Jin, R. C., Zhang, J., You, T., Peng, Z., Ge, X., Bronson, R. T., Halperin, J. A., Loscalzo, J., & Qin, X. (2010) · Blood · doi:10.1182/blood-2010-01-267112 · Cited by 70
Cumming, V., King, L., Fraser, R. A., Serjeant, G. R., & Reid, M. E. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07115.x · Cited by 69
Mukisi-Mukaza, M., Elbaz, A., Leborgne-Samuel, Y., Kélard, L., Turdu-Chicot, C. L., Christophe-Duchange, E., & Mérault, G. (2000) · Orthopedics · doi:10.3928/0147-7447-20000401-17 · Cited by 69
van Beers, E. J., Samsel, L., Mendelsohn, L. G., Saiyed, R., Fertrin, K. Y., Brantner, C. A., Daniels, M. P., Nichols, J., McCoy, J. P., & Kato, G. J. (2014) · American Journal of Hematology · doi:10.1002/ajh.23699 · Cited by 67
Self-citationPhase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease
Doss, J. F., Jonassaint, J., Garrett, M. E., Ashley‐Koch, A. E., Telen, M. J., & Chi, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152895 · Cited by 67
Hemoglobin and free radicals: implications for the development of a safe blood substitute
Alayash, A. I., & Cashon, R. E. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)80089-1 · Cited by 66
Haematological determinants of cardiac involvement in adults with sickle cell disease
Damy, T., Bodez, D., Habibi, A., Guellich, A., Rappeneau, S., Inamo, J., Guendouz, S., Gellen-Dautremer, J., Pissard, S., Loric, S., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv555 · Cited by 65
Voskaridou, E., Tsetsos, G. A., Tsoutsias, A., Spyropoulou, E., Christoulas, D., & Terpos, E. (2007) · Haematologica · doi:10.3324/haematol.11136 · Cited by 64
Machado, R. F., Hildesheim, M. E., Mendelsohn, L. G., Remaley, A. T., Kato, G. J., & Gladwin, M. T. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08777.x · Cited by 63
Self-citationLiem, R. I., Young, L. T., & Thompson, A. A. (2007) · Haematologica · doi:10.3324/haematol.11576 · Cited by 63
Microparticles in sickle cell anaemia: promise and pitfalls
Hebbel, R. P., & Key, N. S. (2016) · British Journal of Haematology · doi:10.1111/bjh.14112 · Cited by 63
Mahadeo, K. M., Oyeku, S. O., Taragin, B. H., Rajpathak, S. N., Moody, K., Santizo, R. O., & Driscoll, M. C. (2011) · American Journal of Hematology · doi:10.1002/ajh.22103 · Cited by 62
Gordeuk, V. R., Campbell, A., RANA, S. R., Nouraie, M. S., Niu, X., Minniti, C. P., Sable, C., Darbari, D. S., Dham, N., Onyekwere, O. C., et al. (2009) · Blood · doi:10.1182/blood-2009-04-218040 · Cited by 61
Self-citationTaylor, J. G., Ackah, D., Cobb, C., Orr, N., Percy, M. J., Sachdev, V., Machado, R. F., Castro, O. L., Kato, G. J., Chanock, S. J., et al. (2007) · American Journal of Hematology · doi:10.1002/ajh.21035 · Cited by 60
Self-citationLandburg, P. P., Teerlink, T., Biemond, B. J., Brandjes, D. P. M., Muskiet, F. A. J., Duits, A. J., & Schnog, J. B. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.02.005 · Cited by 59
Vinchi, F., & Tolosano, E. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/396527 · Cited by 59
Cellular Adhesion and the Endothelium
Telen, M. J. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.010 · Cited by 59
Cellular Adhesion and the Endothelium
Kutlar, A., & Embury, S. H. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.007 · Cited by 58
Dham, N., Ensing, G. J., Minniti, C. P., Campbell, A., Arteta, M., RANA, S. R., Darbari, D. S., Nouraie, M. S., Onyekwere, O. C., Lasota, M., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.034 · Cited by 58
Self-citationCox, S. E., Makani, J., Soka, D., L’Esperence, V., Kija, E., Domínguez-Salas, P., Newton, C. R. J. C., Birch, A. A., Prentice, A. M., & Kirkham, F. J. (2014) · British Journal of Haematology · doi:10.1111/bjh.12791 · Cited by 57
Gall stones in Jamaican children with homozygous sickle cell disease.
Webb, D. K. H., Darby, J. S., Dunn, D. T., Terry, S. I., & Serjeant, G. R. (1989) · Archives of Disease in Childhood · doi:10.1136/adc.64.5.693 · Cited by 57
Nébor, D., Broquère, C., Brudey, K., Mougenel, D., Tarer, V., Connes, P., Élion, J., & Romana, M. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.06.003 · Cited by 57
Kassa, T., Jana, S., Strader, M. B., Meng, F., Jia, Y., Wilson, M. T., & Alayash, A. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.651257 · Cited by 57
Laboratory and echocardiography markers in sickle cell patients with leg ulcers
Minniti, C. P., Taylor, J. G., Hildesheim, M. E., Oneal, P. A., Wilson, J., Castro, O. L., Gordeuk, V. R., & Kato, G. J. (2011) · American Journal of Hematology · doi:10.1002/ajh.22065 · Cited by 56
Self-citationQuinn, C. T., Smith, E. P., Arbabi, S., Khera, P. K., Lindsell, C. J., Niss, O., Joiner, C. H., Franco, R. S., & Cohen, R. M. (2016) · American Journal of Hematology · doi:10.1002/ajh.24562 · Cited by 55
Genetic determinants of haemolysis in sickle cell anaemia
Milton, J. N., Rooks, H., Drašar, E., McCabe, E. L., Baldwin, C. T., Melista, E., Gordeuk, V. R., Nouraie, M. S., Kato, G. R., Minniti, C. P., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12245 · Cited by 54
Self-citationVascular dysfunction in a murine model of severe hemolysis
Frei, A. C., Guo, Y. H., Jones, D. W., Pritchard, K. A., Fagan, K. A., Hogg, N., & Wandersee, N. J. (2008) · Blood · doi:10.1182/blood-2007-12-126714 · Cited by 54
Placenta growth factor in sickle cell disease: association with hemolysis and inflammation
Brittain, J. E., Hulkower, B., Jones, S., Strayhorn, D., Castro, L. D., Telen, M. J., Orringer, E. P., Hinderliter, A. L., & Ataga, K. I. (2009) · Blood · doi:10.1182/blood-2009-04-217950 · Cited by 54
Vercellotti, G. M., Zhang, P., Nguyen, J., Abdulla, F. A., Chen, C., Nguyen, P., Nowotny, C., Steer, C. J., Smith, A., & Belcher, J. D. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00063 · Cited by 51
Joly, P., Garnier, N., Kébaïli, K., Renoux, C., Dony, A., Cheikh, N., Renard, C., Ceraulo, A., Cuzzubbo, D., Pondarré, C., et al. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12607 · Cited by 50
Increased Pulmonary Pressures and Myocardial Wall Stress in Children with Severe Malaria
Janka, J., Koita, O., Traoré, B., Traoré, J. M., Mzayek, F., Sachdev, V., Wang, X., Sanogo, K. M., Sangaré, L., Mendelsohn, L. G., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/655225 · Cited by 50
Self-citationThe Influence of Fetal Hemoglobin on the Clinical Expression of Sickle Cell Anemia a
Powars, D., Chan, L. S., & Schroeder, W. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24174.x · Cited by 49
Heimlich, J. B., Speed, J. S., O'Connor, P. M., Pollock, J. S., Townes, T. M., Meiler, S. E. L., Kutlar, A., & Pollock, D. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13380 · Cited by 49
Belcher, J. D., Marker, P. H., Geiger, P. G., Girotti, A. W., Steinberg, M. H., Hebbel, R. P., & Vercellotti, G. M. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90191-9 · Cited by 47
Self-citationAlbuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia
Hamideh, D., Raj, V. M. S., Harrington, T. J., Li, H., Margolles, E., Amole, F., Garcia-Buitrago, M. T., Ruiz, P., B, G. Z., & Alvarez, O. A. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2821-8 · Cited by 46
Wang, X., Mendelsohn, L. G., Rogers, H. M., Leitman, S. F., Raghavachari, N., Yang, Y., Yau, Y. Y., Tallack, M. R., Perkins, A. C., Taylor, J. G., et al. (2014) · Blood · doi:10.1182/blood-2013-11-539718 · Cited by 45
Self-citationYu, B., Lei, C., Baron, D. M., Steinbicker, A. U., Bloch, K. D., & Zapol, W. M. (2012) · Transfusion · doi:10.1111/j.1537-2995.2011.03473.x · Cited by 44
Prevalence and predictors of microalbuminuria in Jamaican children with sickle cell disease
King, L., MooSang, M., Miller, M., & Reid, M. E. (2011) · Archives of Disease in Childhood · doi:10.1136/archdischild-2011-300628 · Cited by 43
Caughey, M. C., Poole, C., Ataga, K. I., & Hinderliter, A. L. (2015) · British Journal of Haematology · doi:10.1111/bjh.13447 · Cited by 41
Ataga, K. I., Derebail, V. K., Caughey, M. C., Elsherif, L., Shen, J. H., Jones, S., Maitra, P., Pollock, D. M., Cai, J., Archer, D. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162652 · Cited by 41
Insight onto the Pathophysiology and Clinical Complications of Thalassemia Intermedia
Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2009) · Hemoglobin · doi:10.3109/03630260903351528 · Cited by 38
Red Cell Life Span in Sickle Cell Trait
Barbedo, M. M. R., & McCurdy, P. R. (2009) · Acta Haematologica · doi:10.1159/000208316 · Cited by 38
Lei, C., Yu, B., Shahid, M., Beloiartsev, A., Bloch, K. D., & Zapol, W. M. (2012) · Anesthesiology · doi:10.1097/aln.0b013e318272d866 · Cited by 36
Wali, Y. A. M. S., Al‐Lamki, Z., Hussein, S., Bererhi, H., Kumar, D., Wasifuddin, S. M., Zachariah, M., & Ghosh, K. (2002) · Pediatric Hematology and Oncology · doi:10.1080/08880010290097314 · Cited by 35
Mikobi, T. M., Lukusa-Tshilobo, P., Aloni, M. N., Lelo, G. M., Akilimali, P. Z., Muyembe-Tamfum, J. J., Race, V., Matthijs, G., & Mwamba, J. M. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123568 · Cited by 34
Sickle cell retinopathy in Jamaican children: a search for prognostic factors.
Talbot, J. F., Bird, A. C., Rabb, L., Maude, G. H., & Serjeant, G. R. (1983) · British Journal of Ophthalmology · doi:10.1136/bjo.67.11.782 · Cited by 34
Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice
Ghosh, S., Ihunnah, C. A., Hazra, R., Walker, A. L., Hansen, J. M., Archer, D. R., Owusu-Ansah, A. T., & Ofori-Acquah, S. F. (2016) · JCI Insight · doi:10.1172/jci.insight.81090 · Cited by 33
Belisário, A. R., Nogueira, F. L., Rodrigues, R. S., de Toledo, N. E., Cattabriga, A. L. M., Velloso‐Rodrigues, C., Duarte, F. O. C., Silva, C. M., & Viana, M. B. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.08.001 · Cited by 30
Hypoxia/reoxygenation stress increases markers of vaso-occlusive crisis in sickle SAD mice
Aufradet, É., DeSouza, G., Bourgeaux, V., Bessaad, A., Campion, Y., Canet‐Soulas, E., Pialoux, V., Chirico, E. N., Chevrier, A., Godfrin, Y., et al. (2013) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-131735 · Cited by 27
Adenosine deaminase–adenosine pathway in hemolysis-associated pulmonary hypertension
Tofovic, S. P., Jackson, E. K., & Rafikova, O. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.043 · Cited by 27
Forrest, S. J., Kim, A., Carbonella, J., & Pashankar, F. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23338 · Cited by 26
Echocardiographic findings in patients with sickle cell disease
Naoman, S. G., Nouraie, M. S., Castro, O. L., Nwokolo, C., Fadojutimi-Akinsiku, M., Diaz, S. F., Willie-Carnegie, G., Andrews, N., & Gordeuk, V. R. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0764-0 · Cited by 25
HETEROCELLULAR HEREDITARY PERSISTENCE OF FETAL HÆMOGLOBIN AND HOMOZYGOUS SICKLE-CELL DISEASE
Serjeant, G., Serjeant, B. E., & Mason, K. P. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92976-2 · Cited by 24
Pulmonary Hypertension in Sickle Cell Disease
Gladwin, M. T. (2009) · CRC Press eBooks · doi:10.3109/9781420094763-19 · Cited by 22
Self-citationCaughey, M. C., Hinderliter, A. L., Jones, S., Shah, S. P., & Ataga, K. I. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.11.067 · Cited by 21
Limitations of Hb F as a Phenotypic Modifier in Sickle Cell Disease: Study of Kuwaiti Arab Patients
Adekile, A. D. (2011) · Hemoglobin · doi:10.3109/03630269.2011.617230 · Cited by 19
van Beers, E. J., Nur, E., Schaefer‐Prokop, C. M., Gillavry, M. R. M., van Esser, J. W. J., Brandjes, D. P. M., Kappers‐Klunne, M. C., Duits, A. J., Muskiet, F. A. J., Schnog, J. B., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21272 · Cited by 19
A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia
Hanson, M. S., Xu, H., Flewelen, T. C., Holzhauer, S., Retherford, D. M., Jones, D. W., Frei, A. C., Pritchard, K. A., Hillery, C. A., Hogg, N., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00500.2012 · Cited by 16
Influence of alpha thalassaemia on the retinopathy of homozygous sickle cell disease.
Fox, P. D., Higgs, D. R., & Serjeant, G. R. (1993) · British Journal of Ophthalmology · doi:10.1136/bjo.77.2.89 · Cited by 16
Lorch, D. G., Spevack, D. M., & Little, J. A. (2011) · Acta Haematologica · doi:10.1159/000323464 · Cited by 14
TRV: A physiological biomarker in sickle cell disease
Kato, G. J. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23399 · Cited by 14
Self-citationAtaga, K. I., Hinderliter, A. L., Brittain, J. E., Jones, S., Xu, H., Cai, J., Kim, S., Pritchard, K. A., & Hillery, C. A. (2014) · Hematology · doi:10.1179/1607845414y.0000000171 · Cited by 14
Nguyen, K., Tian, X., Alam, S., Mehari, A., Leung, S., Seamon, C., Allen, D. T., Minniti, C. P., Sachdev, V., Arai, A. E., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.125229 · Cited by 14
Self-citationUpadhya, B., Stacey, R. B., Ntim, W. O., Knovich, M. A., & Pu, M. (2014) · Acta Haematologica · doi:10.1159/000357393 · Cited by 13
Alpha thalassaemia and the macular vasculature in homozygous sickle cell disease.
Condon, P. I., Marsh, R. J., Maude, G. H., Higgs, D. R., Weatherall, D. J., & Serjeant, G. R. (1983) · British Journal of Ophthalmology · doi:10.1136/bjo.67.11.779 · Cited by 9
Diop, S. N., Diop, D., Seck, M., Guèye, Y. B., Faye, A., Dièye, T. N., Fall, A. O. T., Diallo, A., Thiam, D., & Diakhaté, L. (2010) · PubMed · Cited by 9
Hamad, Z., Aljedai, A., Halwani, R., & Alsultan, A. S. (2013) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2013.372 · Cited by 8
Anti‐haemolytic effect of senicapoc and decrease in NT‐proBNP in adults with sickle cell anaemia
Minniti, C. P., Wilson, J., Mendelsohn, L. G., Rigdon, G. C., Stocker, J. W., Remaley, A. T., & Kato, G. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08757.x · Cited by 6
Self-citationPulmonary hypertension in sickle cell disease
Machado, R. (2009) · PVRI Review · doi:10.4103/0974-6013.44873 · Cited by 5
Research works printed but not linked: 1
- 10.1038/nm1202-799 · DOI · Paper page
Cited by
Sorted by citations
Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Self-citationPathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Self-citationA Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Vichinsky, E. P., Hoppe, C. C., Ataga, K. I., Ware, R. E., Nduba, V., El-Beshlawy, A. M., Hassab, H. M. A., Achebe, M. M., Alkindi, S. S. A., Brown, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903212 · Cited by 634
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
Dhuri, K., Bechtold, C., Quijano, E., Pham, H. T. T., Gupta, A., Vikram, A., & Bahal, R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9062004 · Cited by 586
Arginase: A Multifaceted Enzyme Important in Health and Disease
Caldwell, R. W., Rodriguez, P. C., Toque, H. A., Narayanan, S. P., & Caldwell, R. B. (2018) · Physiological Reviews · doi:10.1152/physrev.00037.2016 · Cited by 495
Metadata
- Authors
- Kato, G. J., Steinberg, M. H., & Gladwin, M. T.
- Affiliations
- University of Pittsburgh (US)
- Boston University (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Journal of Clinical Investigation
- Published
- 2017-03-01
- Volume
- 127
- Issue
- 3
- Pages
- 750-760
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5330745
- OpenAlex
- W2592339311
- Semantic Scholar
- 0c9beb4e3a557982862ac3ec381a89baab12ceae
- Cited by
- 748
- References
- 193
- Citations by year
- 2026: 90 · 2025: 81 · 2024: 76 · 2023: 65 · 2022: 116 · 2021: 81 · 2020: 87 · 2019: 76 · 2018: 53 · 2017: 21
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Patient-Centered Outcomes Research Institute
- University of Pittsburgh
- Hemophilia Center of Western Pennsylvania
- National Institutes of Health (HL098032)
- National Heart, Lung, and Blood Institute (R01HL087681, R01HL068970, P01HL103455, RC2HL101212, R01HL121386, U01HL107443, T32HL007501, R01HL125886, R01HL098032, T32HL110849)
- National Institute on Minority Health and Health Disparities (R01MD009162)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- intravascular hemolysis, sickle cell disease, free hemoglobin, nitric oxide, methemoglobin, heme, arginase-1, asymmetric dimethylarginine, adenine nucleotides, pulmonary hypertension, inflammation
- MeSH terms
- Anemia, Sickle Cell, Hemolysis, Humans, Methemoglobin, Nitric Oxide, Vascular Diseases, Vasomotor System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
